|
1
|
Libby P, Ridker PM and Hansson GK; Leducq
Transatlantic Network on Atherothrombosis: Inflammation in
atherosclerosis: From pathophysiology to practice. J Am Coll
Cardiol. 54:2129–2138. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Galkina E and Ley K: Vascular adhesion
molecules in atherosclerosis. Arterioscler Thromb Vasc Biol.
27:2292–2301. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Davignon J and Ganz P: Role of endothelial
dysfunction in atherosclerosis. Circulation. 109(Suppl 1):
III27–III32. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hou HF, Yuan N, Guo Q, Sun T, Li C, Liu
JB, Li QW and Jiang BF: Citreoviridin enhances atherogenesis in
hypercholesterolemic ApoE-deficient mice via upregulating
inflammation and endothelial dysfunction. PLoS One.
10:e01259562015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xu S, Song H, Huang M, Wang K, Xu C and
Xie L: Telmisartan inhibits the proinflammatory effects of
homocysteine on human endothelial cells through activation of the
peroxisome proliferator-activated receptor-δ pathway. Int J Mol
Med. 34:828–834. 2014.PubMed/NCBI
|
|
6
|
Carluccio MA, Siculella L, Ancora MA,
Massaro M, Scoditti E, Storelli C, Visioli F, Distante A and De
Caterina R: Olive oil and red wine antioxidant polyphenols inhibit
endothelial activation: Antiatherogenic properties of Mediterranean
diet phytochemicals. Arterioscler Thromb Vasc Biol. 23:622–629.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Baker RG, Hayden MS and Ghosh S: NF-κB
inflammation, and metabolic disease. Cell Metab. 13:11–22. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Brown JD, Lin CY, Duan Q, Griffin G,
Federation AJ, Paranal RM, Bair S, Newton G, Lichtman AH, Kung AL,
et al: NF-κB directs dynamic super enhancer formation in
inflammation and atherogenesis. Mol Cell. 56:219–231. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Barnes PJ and Karin M: Nuclear
factor-kappaB: a pivotal transcription factor in chronic
inflammatory diseases. N Engl J Med. 336:1066–1071. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Collins T: Endothelial nuclear
factor-kappa B and the initiation of the atherosclerotic lesion.
Lab Invest. 68:499–508. 1993.PubMed/NCBI
|
|
11
|
Mallavia B, Recio C, Oguiza A, Ortiz-Muñoz
G, Lazaro I, Lopez-Parra V, Lopez-Franco O, Schindler S, Depping R,
Egido J and Gomez-Guerrero C: Peptide inhibitor of NF-κB
translocation ameliorates experimental atherosclerosis. Am J
Pathol. 182:1910–1921. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pamukcu B, Lip GY and Shantsila E: The
nuclear factor-kappa B pathway in atherosclerosis: a potential
therapeutic target for atherothrombotic vascular disease. Thromb
Res. 128:117–123. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Usatyuk PV and Natarajan V: Role of
mitogen-activated protein kinases in 4-hydroxy-2-nonenal-induced
actin remodeling and barrier function in endothelial cells. J Biol
Chem. 279:11789–11797. 2004. View Article : Google Scholar
|
|
14
|
Meshnick SR, Taylor TE and
Kamchonwongpaisan S: Artemisinin and the antimalarial
endoperoxides: From herbal remedy to targeted chemotherapy.
Microbiol Rev. 60:301–315. 1996.PubMed/NCBI
|
|
15
|
World Health Organization: Guidelines for
the Treatment of Malaria. ISBN: 92-4-154694-8Geneva; 2006
|
|
16
|
Ho WE, Peh HY, Chan TK and Wong WS:
Artemisinins: Pharmacological actions beyond anti-malarial.
Pharmacol Ther. 142:126–139. 2014. View Article : Google Scholar
|
|
17
|
Wang Y, Huang Z, Wang L, Meng S, Fan Y,
Chen T, Cao J, Jiang R and Wang C: The anti-malarial artemisinin
inhibits pro-inflammatory cytokines via the NF-κB canonical
signaling pathway in PMA-induced THP-1 monocytes. Int J Mol Med.
27:233–241. 2011. View Article : Google Scholar
|
|
18
|
Wang Y, Huang ZQ, Wang CQ, Wang LS, Meng
S, Zhang YC, Chen T and Fan YQ: Artemisinin inhibits extracellular
matrix metalloproteinase inducer (EMMPRIN) and matrix
metallopro-teinase-9 expression via a protein kinase
Cδ/p38/extracellular signal-regulated kinase pathway in phorbol
myristate acetate-induced THP-1 macrophages. Clin Exp Pharmacol
Physiol. 38:11–18. 2011. View Article : Google Scholar
|
|
19
|
Lamon BD and Hajjar DP: Inflammation at
the molecular interface of atherogenesis: an anthropological
journey. Am J Pathol. 173:1253–1264. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Blankenberg S, Barbaux S and Tiret L:
Adhesion molecules and atherosclerosis. Atherosclerosis.
170:191–203. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Davies MJ, Gordon JL, Gearing AJH, Pigott
R, Woolf N, Katz D and Kyriakopoulos A: The expression of the
adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human
atherosclerosis. J Pathol. 171:223–229. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xia F, Wang C, Jin Y, Liu Q, Meng Q, Liu K
and Sun H: Luteolin protects HUVECs from TNF-α-induced oxidative
stress and inflammation via its effects on the Nox4/ROS-NF-κB and
MAPK pathways. J Atheroscler Thromb. 21:768–783. 2014. View Article : Google Scholar
|
|
23
|
Koo HJ, Sohn EH, Pyo S, Woo HG, Park DW,
Ham YM, Jang SA, Park SY and Kang SC: An ethanol root extract of
Cynanchum wilfordii containing acetophenones suppresses the
expression of VCAM-1 and ICAM-1 in TNF-α-stimulated human aortic
smooth muscle cells through the NF-κB pathway. Int J Mol Med.
35:915–924. 2015.PubMed/NCBI
|
|
24
|
Libby P: Inflammation in atherosclerosis.
Arterioscler Thromb Vasc Biol. 32:2045–2051. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hansson GK: Inflammation, atherosclerosis,
and coronary artery disease. N Engl J Med. 352:1685–1695. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Blankenberg S, Rupprecht HJ, Bickel C,
Peetz D, Hafner G, Tiret L and Meyer J: Circulating cell adhesion
molecules and death in patients with coronary artery disease.
Circulation. 104:1336–1342. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gustin JA, Pincheira R, Mayo LD, Ozes ON,
Kessler KM, Baerwald MR, Korgaonkar CK and Donner DB: Tumor
necrosis factor activates CRE-binding protein through a p38
MAPK/MSK1 signaling pathway in endothelial cells. Am J Physiol Cell
Physiol. 286:C547–C555. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Monaco C and Paleolog E: Nuclear factor
kappaB: A potential therapeutic target in atherosclerosis and
thrombosis. Cardiovasc Res. 61:671–682. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
de Winther MP, Kanters E, Kraal G and
Hofker MH: Nuclear factor kappaB signaling in atherogenesis.
Arterioscler Thromb Vasc Biol. 25:904–914. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang Y, Yang X, Bian F, Wu P, Xing S, Xu
G, Li W, Chi J, Ouyang C, Zheng T, et al: TNF-α promotes early
atherosclerosis by increasing transcytosis of LDL across
endothelial cells: Crosstalk between NF-κB and PPAR-γ. J Mol Cell
Cardiol. 72:85–94. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Anderson MT, Staal FJ, Gitler C and
Herzenberg LA and Herzenberg LA: Separation of oxidant-initiated
and redox-regulated steps in the NF-kappa B signal transduction
pathway. Proc Natl Acad Sci USA. 91:11527–11531. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Collins T, Read MA, Neish AS, Whitley MZ,
Thanos D and Maniatis T: Transcriptional regulation of endothelial
cell adhesion molecules: NF-kappa B and cytokine-inducible
enhancers. FASEB J. 9:899–909. 1995.PubMed/NCBI
|
|
33
|
Lu Y, Zhu X, Liang GX, Cui RR, Liu Y, Wu
SS, Liang QH, Liu GY, Jiang Y, Liao XB, et al: Apelin-APJ induces
ICAM-1, VCAM-1 and MCP-1 expression via NF-κB/JNK signal pathway in
human umbilical vein endothelial cells. Amino Acids. 43:2125–2136.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ju H, Behm DJ, Nerurkar S, Eybye ME,
Haimbach RE, Olzinski AR, Douglas SA and Willette RN: p38 MAPK
inhibitors ameliorate target organ damage in hypertension: Part 1.
p38 MAPK-dependent endothelial dysfunction and hypertension. J
Pharmacol Exp Ther. 307:932–938. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Surapisitchat J, Hoefen RJ, Pi X,
Yoshizumi M, Yan C and Berk BC: Fluid shear stress inhibits
TNF-alpha activation of JNK but not ERK1/2 or p38 in human
umbilical vein endothelial cells: Inhibitory crosstalk among MAPK
family members. Proc Natl Acad Sci USA. 98:6476–6481. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cao Q, Jiang Y, Shi J, Xu C, Liu X, Yang
T, Fu P and Niu T: Artemisinin inhibits the proliferation,
migration, and inflammatory reaction induced by tumor necrosis
factor-α in vascular smooth muscle cells through nuclear factor
kappa B pathway. J Surg Res. 194:667–678. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tripathi AK, Sullivan DJ and Stins MF:
Plasmodium falciparum-infected erythrocytes increase intercellular
adhesion molecule 1 expression on brain endothelium through
NF-kappaB. Infect Immun. 74:3262–3270. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Souza MC, Paixão FH, Ferraris FK, Ribeiro
I and Henriques Md: Artesunate exerts a direct effect on
endothelial cell activation and NF-κB translocation in a mechanism
independent of plasmodium killing. Malar Res Treat.
679090(2012)2012.
|
|
39
|
Li WD, Dong YJ, Tu YY and Lin ZB:
Dihydroarteannuin ameliorates lupus symptom of BXSB mice by
inhibiting production of TNF-alpha and blocking the signaling
pathway NF-kappa B translocation. Int Immunopharmacol. 6:1243–1250.
2006. View Article : Google Scholar : PubMed/NCBI
|
